The same protein expression pattern was observed in human SCLC cells treated with dinaciclib, including downregulation of BCL-xL and increased levels of cleaved Caspase-3 and PARP, indicating activation of apoptosis upon treatment (Fig. 1E). The gene discussed is CASP3; the disease is small cell lung carcinoma.